Clinical characteristics of the study patients in transition to the Adult Asthma Center
| Individual data | Case 1 | Case 2 | Case 3 | Case 4 |
|---|---|---|---|---|
| Symptoms burden | Exercise-induced dyspnea | Nasal obstruction, hyposmia | Exercise-induced dyspnea, nasal obstruction | Cough, exercise-induced dyspnea |
| T2-related comorbidity | Allergic rhinoconjunctivitis, atopic dermatitis | Allergic rhinoconjunctivitis, CRSwNP | Allergic rhinoconjunctivitis | Allergic rhinoconjunctivitis, atopic dermatitis |
| NonT2-related comorbidity | No | No | Insulin resistance; obesity | No |
| Adolescents risk factors* | No | No | No | No |
| Self-management capacity§ | 1 | 1 | 1 | 1 |
| Length of biologic treatment at transition | 5 years | 2 years | 2 years | 9 years |
* Smoking, alcohol and illicit drugs, depression, sexuality and suicide risk. § (Based on clinical evaluation): 0—does not independently adhere to therapy and is accompanied by parents to medical appointments; 1—independently adheres to therapy and is accompanied by parents to medical appointments; 2—independently adheres to therapy and is not accompanied by parents to medical appointments. CRSwNP: chronic rhinosinusitis with nasal polyps